As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.

by Jon Kelvey

FDA proposes ban on menthol cigarettes, and proton beam therapy on the rise but with growing racial disparity.

by Thomas Celona

Study finds a connection between bacteria and fast-growing prostate cancer, and researchers measure underrepresentation of Black patients in clinical trials.

by Kevin McLaughlin

Experts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation.

by Thomas Celona

Trial of ‘practice-changing’ immunotherapy yields positive results for lung cancer patients, and CAR T-cell therapy shows effectiveness in targeting certain solid tumors.

by Thomas Celona

Researchers are investigating how to match specific dietary changes with therapy to impede cancer progression.

by Thomas Celona

A symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.

by Eric Fitzsimmons

Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.

by Marci A. Landsmann

An AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.

by Marci A. Landsmann

DNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising questions about how to best treat recurrence.

by Eric Fitzsimmons